tiprankstipranks
Acerus Pharmaceuticals (ASPCQ)
OTHER OTC:ASPCQ
Holding ASPCQ?
Track your performance easily

Acerus Pharmaceuticals (ASPCQ) Stock Price & Analysis

0 Followers

ASPCQ Stock Chart & Stats


Acerus Pharmaceuticals News

Acerus Update
PremiumPress Releases
Acerus Update
1y ago
Acerus Update
PremiumPress Releases
Acerus Update
2y ago

Financials

Annual

ASPCQ FAQ

What was Acerus Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Acerus Pharmaceuticals’s market cap?
Currently, no data Available
When is Acerus Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Acerus Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Acerus Pharmaceuticals overvalued?
According to Wall Street analysts Acerus Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Acerus Pharmaceuticals pay dividends?
    Acerus Pharmaceuticals does not currently pay dividends.
    What is Acerus Pharmaceuticals’s EPS estimate?
    Acerus Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Acerus Pharmaceuticals have?
    Currently, no data Available
    What happened to Acerus Pharmaceuticals’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Acerus Pharmaceuticals?
    Currently, no hedge funds are holding shares in ASPCQ
    ---

    Acerus Pharmaceuticals Stock Smart Score

    10
    Unlock Smart Score
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Company Description

    Acerus Pharmaceuticals

    Acerus Pharmaceuticals Corp. engages in the development, manufacture, production, marketing, and distribution of women's and men's health products. It focuses on therapeutics for urology, hormone replacement therapy, and female dysfunction. Its products include Estrace, Natesto, Gynoflor, and Tefina. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus, and Mark L. Thompson in October 2008 and is headquartered in Mississauga, Canada.
    ---
    Similar Stocks
    Company
    Price & Change
    Follow
    Cormedix
    Aileron Therapeutics
    Immutep
    Citius Pharmaceuticals
    Popular Stocks
    ---
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis